Open communication about all medications, supplements, and lifestyle factors ensures safer and more effective semaglutide use
In the treatment of type 1 diabetes, Ozempic is not recommended
My cravings have eased, I haven't got the same amount of bloating around my tummy and I'm not constantly reaching for the snacks
That said, not all peptides are created equal
Mayo Clinic says this new lifetime maximum benefit does not apply to "approved GLP-1 prescriptions for diabetes." Semaglutide, the active ingredient in Wegovy, is a glucagon-like peptide 1 agonist and is FDA-approved for type 2 diabetes treatment under the brand name Ozempic
No, MOTS-c is still an experimental peptide being explored for therapeutic purposes related to aging and obesity